DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

LinksClose Window

References

Rini B, Hutson T, Elson P.
Phase II Study of Sorafenib in patients with mRCC refractory to Sunitinib or Bevacizumab.
In: ASCO. ed. 2008.
346.

Download Bibliographical Data

We do not assume any responsibility for the contents of the web pages of other providers.